News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
229,034 Results
Type
Article (7177)
Company Profile (16)
Press Release (221841)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (63168)
Career Advice (295)
Deals (14772)
Drug Delivery (28)
Drug Development (36808)
Employer Resources (24)
FDA (6415)
Job Trends (4911)
News (121875)
Policy (11635)
Tag
Academia (567)
Accelerated approval (2)
Adcomms (7)
Allergies (38)
Alliances (14803)
ALS (29)
Alzheimer's disease (602)
Antibody-drug conjugate (ADC) (47)
Approvals (6463)
Artificial intelligence (110)
Autoimmune disease (10)
Automation (3)
Bankruptcy (147)
Best Places to Work (4609)
BIOSECURE Act (2)
Biosimilars (21)
Biotechnology (18)
Bladder cancer (57)
Brain cancer (15)
Breast cancer (117)
Cancer (1218)
Cardiovascular disease (73)
Career advice (260)
Career pathing (4)
CAR-T (93)
Cell therapy (225)
Cervical cancer (13)
Clinical research (31301)
Collaboration (318)
Compensation (94)
Complete response letters (7)
COVID-19 (724)
CRISPR (19)
C-suite (81)
Cystic fibrosis (38)
Data (1410)
Denatured (1)
Depression (21)
Diabetes (114)
Diagnostics (2237)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (48)
Drug pricing (42)
Drug shortages (17)
Duchenne muscular dystrophy (42)
Earnings (33639)
Editorial (15)
Employer branding (1)
Employer resources (19)
Events (31266)
Executive appointments (254)
FDA (7197)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (278)
Gene editing (48)
Generative AI (10)
Gene therapy (139)
GLP-1 (187)
Government (1254)
Grass and pollen (2)
Guidances (115)
Healthcare (6140)
Huntington's disease (5)
IgA nephropathy (16)
Immunology and inflammation (40)
Indications (17)
Infectious disease (787)
Inflammatory bowel disease (67)
Inflation Reduction Act (5)
Influenza (25)
Intellectual property (55)
Interviews (46)
IPO (8046)
IRA (17)
Job creations (572)
Job search strategy (221)
Kidney cancer (8)
Labor market (5)
Layoffs (41)
Leadership (4)
Legal (2100)
Liver cancer (41)
Lung cancer (169)
Lymphoma (87)
Machine learning (3)
Management (7)
Manufacturing (110)
MASH (42)
Medical device (4591)
Medtech (4592)
Mergers & acquisitions (7104)
Metabolic disorders (289)
Multiple sclerosis (43)
NASH (8)
Neurodegenerative disease (25)
Neuropsychiatric disorders (4)
Neuroscience (823)
NextGen: Class of 2025 (1501)
Non-profit (712)
Obesity (139)
Opinion (76)
Ovarian cancer (57)
Pain (42)
Pancreatic cancer (53)
Parkinson's disease (68)
Partnered (5)
Patents (144)
Patient recruitment (69)
Peanut (17)
People (14565)
Pharmaceutical (8)
Pharmacy benefit managers (7)
Phase I (9997)
Phase II (13780)
Phase III (10317)
Pipeline (884)
Policy (34)
Postmarket research (796)
Preclinical (3679)
Press Release (9)
Prostate cancer (53)
Psychedelics (11)
Radiopharmaceuticals (119)
Rare diseases (160)
Real estate (1005)
Recruiting (7)
Regulatory (9201)
Reports (13)
Research institute (510)
Resumes & cover letters (39)
Rett syndrome (4)
RNA editing (2)
RSV (16)
Schizophrenia (29)
Series A (45)
Series B (34)
Service/supplier (2)
Sickle cell disease (23)
Special edition (2)
Spinal muscular atrophy (31)
Sponsored (14)
Startups (676)
Stomach cancer (5)
Supply chain (26)
Tariffs (4)
The Weekly (1)
Vaccines (173)
Venture capitalists (5)
Weight loss (76)
Women's health (6)
Worklife (4)
Date
Today (19)
Last 7 days (530)
Last 30 days (1501)
Last 365 days (15654)
2025 (5570)
2024 (16927)
2023 (19101)
2022 (22235)
2021 (23635)
2020 (21798)
2019 (14442)
2018 (10637)
2017 (11464)
2016 (9550)
2015 (11755)
2014 (8109)
2013 (5879)
2012 (6046)
2011 (6772)
2010 (6248)
Location
Africa (176)
Alabama (17)
Alaska (2)
Arizona (55)
Arkansas (3)
Asia (17599)
Australia (4857)
California (3098)
Canada (1169)
China (254)
Colorado (127)
Connecticut (171)
Delaware (64)
Europe (28109)
Florida (456)
Georgia (71)
Idaho (6)
Illinois (219)
India (20)
Indiana (128)
Japan (98)
Kansas (15)
Kentucky (6)
Louisiana (5)
Maine (36)
Maryland (373)
Massachusetts (2189)
Michigan (52)
Minnesota (109)
Missouri (36)
Montana (11)
Nebraska (8)
Nevada (45)
New Hampshire (36)
New Jersey (1060)
New Mexico (3)
New York (972)
North Carolina (407)
North Dakota (2)
Northern California (1384)
Ohio (67)
Oklahoma (1)
Oregon (7)
Pennsylvania (712)
Puerto Rico (8)
Rhode Island (8)
South America (302)
South Carolina (14)
Southern California (1191)
Tennessee (45)
Texas (470)
United States (11306)
Utah (75)
Virginia (82)
Washington D.C. (19)
Washington State (353)
West Virginia (2)
Wisconsin (12)
229,034 Results for "cbio limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
1cBio and Alesta Therapeutics Announce Exclusive Global Licensing Agreement for a Novel Potentially First-in-Class Small Molecule for Hypophosphatasia
January 8, 2025
·
3 min read
Drug Development
T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured
Cbio A/S – Pioneering Next-Gen T-Cell Therapies for Solid Tumors, Unveils 2023 Financial Results and Company Updates.
April 12, 2024
·
2 min read
Press Releases
Health Canada approves IMFINZI® (durvalumab) as the first and only immunotherapy regimen for adult patients with limited-stage small cell lung cancer (LS-SCLC)
April 10, 2025
·
6 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
May 6, 2025
·
4 min read
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
April 14, 2025
·
5 min read
Biotech Bay
Catalyst Biosciences Regains Rights to CB 2782-PEG for the Treatment of Dry AMD Expands CBIO’s Complement Portfolio in Ophthalmology
Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that the company has regained full rights to CB 2782-PEG, a C3-degrader for the treatment of dry AMD (dAMD).
March 15, 2022
·
2 min read
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
Layoffs
Pliant Axes 45% of Workforce To Save Cash, Support Late-Stage Clinical Trials
Following challenges with its drug candidate bexotegrast and announcement of a limited-duration stockholder rights program, Pliant is paring back its workforce.
May 2, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Lightcast Announces Limited Commercial Release of Envisia™ Single-Cell Functional Analysis Platform for Antibody Discovery
May 9, 2025
·
3 min read
Press Releases
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
April 7, 2025
·
4 min read
1 of 22,904
Next
